Sr. Associate – Value & Access at Eli Lilly and Company

Seoul, South Korea, South Korea

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Experiences/knowledge of pricing policies & procedure or HEOR (preferred)
Bachelor degree or above majored in pharmacy or health policy (preferred)
Good in English (Speaking and Writing)
Proficient computer skills (MS-Word, Excel, PowerPoint)
Demonstrated ability to work cross-functionally
High level of motivation and a strong desire to find creative solutions to challenging situations
Strong learning agility
Prioritization skills with attention to detail
Ability to systematically review clinical/scientific literature
Ability to analyze and interpret clinical and health outcomes data

Responsibilities

Understand global brand payer strategies for prioritized products for respective business unit and incorporate local payer’s needs and insights into local strategy/deliverables
Understand payer’s or customers’ needs and insights, and communicate internally
Lead the development and execution of pricing and reimbursement strategies & evidence generations including launch, post-launch as well as product development strategies (indication, dosage, potential payer prioritization)
Develop best-in-class dossiers including health economics and budget impact analysis for submission and lead payer negotiation through scientific communication with evidence to achieve reimbursement
Develop strategy on price negotiations with government and governmental authorities (i.e. reimbursement approval for a new drug, price-volume negotiation, RSA reassessment, reimbursement expansion) to minimize price reduction
Coordinate cross functional teams to carry out pre-launch activities, monitor progress of negotiation and get supports from external stakeholders
Assist in the development of payer partnership programs and other relevant tools based on health outcomes / medical data and assist in the cross-affiliate use of dossiers to appropriately support reimbursement
Be responsible for planning, initiating, contracting vendors, analysis and publication of health economics/outcomes studies to support the reimbursement negotiation
Be responsible for local adaptation of pharmaco-economic model
Understand deeply country pharmaceutical and economic environment, and HTA process
Participate in trade associations as appropriate (based on level of association)
Develop business cases for OOP, AAP, and/or reimbursement launches, with support of cross-functional partners
Develop a clear and concise narrative around the Value & Access strategy and financial assessment

Skills

Key technologies and capabilities for this role

Payer MarketingPricing StrategyReimbursement StrategyHealth EconomicsBudget Impact AnalysisHTA SubmissionPharmaco-economic ModelingHEORValue Dossier Development

Questions & Answers

Common questions about this position

What is the employment type for this Sr. Associate – Value & Access role?

This is a full-time position.

Is this role remote or does it require working from a specific location?

This information is not specified in the job description.

What are the key responsibilities or skills required for this position?

Key responsibilities include implementing strategic plans for market access, developing dossiers for HTA submissions, leading pricing and reimbursement strategies, health economics modeling, and managing external customer relationships with payers.

What is the company culture like at Eli Lilly?

Eli Lilly unites caring with discovery to make life better for people, puts people first, and seeks determined individuals who give their best effort while contributing to communities through philanthropy and volunteerism.

What makes a strong candidate for this Sr. Associate – Value & Access role?

Strong candidates should have expertise in payer marketing, HTA submissions, health economics modeling, pricing negotiations, and cross-functional coordination to support product reimbursement throughout the lifecycle.

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free